Plain-English translation of NCT07727681 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether , a medication commonly used to manage cholesterol, can prevent abnormal heart rhythms that sometimes occur after lung surgery. Researchers want to know if taking this medication for about a week — starting a few days before surgery and continuing for three days after — can reduce the chance of developing a dangerously fast or irregular heartbeat. The study will also check that the medication is safe to use in this way.
Abnormal heart rhythms are a common and sometimes serious complication after lung surgery, especially in older adults. Doctors are exploring whether this medication, which has other heart-protective effects, might prevent these rhythm problems from developing in the first place.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll be randomly assigned to receive either the medication or a placebo (a look-alike tablet with no active ingredient) for about one to two weeks total. You'll start taking the assigned treatment 2 to 7 days before your scheduled surgery and continue for 72 hours after surgery. After your operation, you'll wear a portable heart monitor continuously for three days to check for any abnormal rhythms. The research team will also collect blood tests and routine clinical information during your hospital stay and follow up with you 30 days after surgery to ensure you're recovering well.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
China